
Share
Photon aims to revolutionize the clunky electronic prescribing process, securing $16 million to boost its tech and team, promising smoother interactions for both patients and healthcare providers.
Photon, a health tech startup focused on modernizing prescription infrastructure, has secured $16 million in Series A funding. The round was led by Healthier Capital and included participation from Notation, Flare Capital, and Evidenced. This capital infusion will be used to expand Photon’s engineering and commercial teams, as well as to integrate with more health systems and platforms.
The current electronic prescribing system is fraught with inefficiencies that lead to poor patient experiences and administrative burdens for healthcare providers. According to Otto Sipe, founder and CEO of Photon, the lack of transparency in pricing and convenience results in unnecessary prescription transfers, unanswered phone calls, and abandoned fills. These issues create a ripple effect of dissatisfaction among patients, pharmacists, and providers.
Photon aims to revolutionize the prescription experience by providing a full end-to-end platform that integrates seamlessly with EHRs. Patients receive a text message with a link to access their prescriptions digitally, allowing them to see nearby pharmacies, hours of operation, pricing, and inventory. This transparency empowers patients to make informed decisions about where to fill their prescriptions.

According to Sipe, this approach not only reduces administrative work for healthcare providers but also improves patient adherence to prescribed medications. Patients are more likely to pick up their prescriptions when they have clear information about costs and availability, leading to better health outcomes.
Since 2021, Photon has been steadily building its platform and expanding its network of pharmacy partners. The company works with dozens of retail and home delivery pharmacies across the United States. Even if a pharmacy is not a direct partner, Photon uses agentic AI to collect necessary information for patients, ensuring a comprehensive and user-friendly experience.
With the new funding, Photon plans to:
Photon’s innovative approach to modernizing prescription infrastructure addresses a critical need in the healthcare system. By improving transparency and convenience, the company aims to enhance patient satisfaction and adherence while reducing administrative burdens for healthcare providers. As Photon scales its operations, it will be crucial to navigate market competition and regulatory challenges effectively.
Tags
Original Sources
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
30 April 2026
88 articles
Related Articles
Related Articles
More Stories